US Bancorp’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $72.8K | Sell |
1,430
-3
| -0.2% | -$153 | ﹤0.01% | 2597 |
|
|
2025
Q1 | $64.6K | Buy |
1,433
+60
| +4% | +$2.7K | ﹤0.01% | 2611 |
|
|
2024
Q4 | $56.8K | Buy |
1,373
+196
| +17% | +$8.11K | ﹤0.01% | 2675 |
|
|
2024
Q3 | $45.9K | Buy |
1,177
+1,030
| +701% | +$40.2K | ﹤0.01% | 2779 |
|
|
2024
Q2 | $5.03K | Sell |
147
-9
| -6% | -$308 | ﹤0.01% | 3498 |
|
|
2024
Q1 | $3.92K | Buy |
156
+41
| +36% | +$1.03K | ﹤0.01% | 3570 |
|
|
2023
Q4 | $3.4K | Buy |
115
+43
| +60% | +$1.27K | ﹤0.01% | 3600 |
|
|
2023
Q3 | $2.28K | Hold |
72
| – | – | ﹤0.01% | 3615 |
|
|
2023
Q2 | $1.86K | Hold |
72
| – | – | ﹤0.01% | 3669 |
|
|
2023
Q1 | $1.73K | Sell |
72
-68
| -49% | -$1.63K | ﹤0.01% | 3767 |
|
|
2022
Q4 | $2.73K | Buy |
+140
| New | +$2.73K | ﹤0.01% | 3679 |
|